A groundbreaking study reveals how targeting two enzymes, PDIA1 and PDIA5, can weaken prostate cancer cells, enhancing the effectiveness of existing treatments like enzalutamide and improving survival rates.
Naked mole-rats, nature's extraordinary creatures, live up to 37 years thanks to a unique protein that enhances DNA repair. Can this discovery lead to human longevity? Find out more!
New research reveals how distinct cell populations within lung cancer tissues can predict patient responses to immunotherapy, offering insights for personalized treatments and better outcomes.
A groundbreaking study led by Professor Takuya Takahashi reveals a significant connection between elevated AMPA receptor density and cognitive symptoms in Long COVID patients. This finding could lead to new diagnostic and treatment strategies.
Discover how advancements in breast cancer treatment over the past 40 years have led to declining death rates and improved survival rates. Experts reveal encouraging trends in early diagnosis and effective therapies.
In a race against time, Bear River Health officials moved swiftly to protect 11 exposed infants from measles, coordinating a vital response that involved notifying families and administering urgent treatments.
Recent advancements in Alzheimer's research have unveiled two new drugs and a pioneering blood test, igniting hope among patients. However, their effectiveness and safety raise significant concerns as debates continue over the best treatment approaches.
Pfizer is making headlines with its $7.3 billion acquisition of Metsera, a weight loss drugmaker, as it aims to capture a share of the booming obesity drug market. This deal highlights the growing demand for innovative obesity treatments and Pfizer's strategic pivot following setbacks in its own drug pipeline.
The CDC's vaccine advisory panel is under fire as Health Secretary Robert F. Kennedy Jr. appoints a Maui physician known for controversial Covid treatments. Will this shake public trust in vaccines even further?
New research reveals that chronic insomnia not only leads to fatigue but also increases the risk of cognitive decline by 40%. Discover how treating insomnia can potentially safeguard your brain health as you age!
